AGP Picks
View all

Tech Daily Missouri: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Missouri.

Press releases published on August 20, 2026

AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial
George Medicines announces GMRx2 presentations at the European Society of Cardiology Congress 2026
ARRAY Technologies to Detail Balance-of-System Strategy and APA Long-Term Growth Opportunities at the APA Investor Technology Showcase Today
Verano Enters Cannabis Beverage Category with Debut of Easy Landings, Company’s First National Beverage Brand Featuring Four Delicious Flavors and All-Natural Ingredients
Nurix Therapeutics Announces Appointment of Wes Burwell  as Chief Human Resources Officer
Harrow Announces IHEEZO® Data in Patient-Reported Discomfort Following Intravitreal Injections
Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
UroGen Announces Strategic Collaboration and Investment Agreements with IntraGel to Access Biodegradable Sustained-Release Gel Platform and Expand Oncology Pipeline
RentRedi is the Best Property Management Software in 2026, According to Independent Market Intelligence
Aurora Mobile Limited Announces Second Quarter 2026 Unaudited Financial Results
Shufti Launches Flagship Podcast Series Called ‘Built By Shufti’ Showcasing a Decade of Custom Innovation for 2,000+ Businesses
Rehza Launches AI Platform Transforming the Home Builder and Homeowner Experience
Jiayin Group Inc. Releases 2025 Environmental, Social and Governance (ESG) Report
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
BioNTech präsentiert auf der WCLC 2026 Fortschritte ihrer spätklinischen Pipeline bei Lungenkrebs und erste globale Daten zur innovativen Behandlungskombination aus Pumitamig und Elfetabart Drozuntecan
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
Tone Commander Secure SIP Phones Obtain Fresh JITC/STIG Certifications
Huize Holding Limited Reports Unaudited Financial Results for the First Half of 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Daily Missouri

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.